Evaluation of Outcomes From Treatment of Benign or Malignant Gastroesophageal Diseases | MicrobiomeTrials← Back to trialsNCT04637256
Evaluation of Outcomes From Treatment of Benign or Malignant Gastroesophageal Diseases
CompletedOBSERVATIONAL
Trial Details
Start: 2019-03-06Est. Completion: 2021-02-27
Enrollment target: 500 participants Locations- Trinity Surgical Consultants, Methodist Richardson Medical Center, Richardson, Texas, United States
Other microbiome trials you might be interested in
Pancreatic Ductal Adenocarcinoma (PDAC)NGS Monitor MRD
Pancreatic ductal adenocarcinoma (PDAC) carries one of the worst prognoses among solid tumors. Even after curative-inten…
Taoyuan, TaiwanEst. completion Apr 30, 2029
Malignant Tumor
Advanced solid tumors remain a major therapeutic challenge due to their complex heterogeneity and the immunosuppressive …
Chengdu, ChinaEst. completion Dec 31, 2026